2026-11-10 17:55:27 UTC#610418newreportednews
Pfizer (PFE) stock news
Pfizer (PFE) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-11-09 17:36:23 UTC#602133updateconfirmednews
MediciNova outlines strategic focus on CD228V, SkinJect SPAC, and Teverelix partnerships following Q3 results
2026-11-07 02:31:00 UTC#593714newconfirmedanalysis
Rising Chinese Pharmaceutical Innovation Poses Long-Term Competitive Threat to Global Drugmakers, Barron's Reports
dow_jonesimportance 0.40trust 0.80Merck & Co., Inc. +0.20Sichuan-Kelun Pharmaceutical Co., Ltd. +0.40Akeso, Inc. +0.40+2 entities
2026-11-07 00:12:17 UTC#593446newconfirmednews
Freedom Broker maintains Pfizer at Buy, raises price target to $34 from $33
2026-11-04 23:06:23 UTC#575885newconfirmednews
UBS maintains Pfizer at Neutral, raises price target to $30 from $27
2026-11-04 21:24:00 UTC#575317newconfirmednews
Citigroup maintains Pfizer at Neutral, raises price target to $30 from $27
2026-11-04 17:10:34 UTC#573418newconfirmednews
RBC Capital maintains Pfizer at Sector Perform, raises price target to $28 from $25
2026-11-04 13:05:42 UTC#571448newconfirmednews
United Therapeutics acquires Pfizer royalty rights for lung disease therapy
2026-11-04 05:36:39 UTC#568639duplicateconfirmednews
Pfizer reiterates 2026 guidance of $62B-$64B revenue and $2.95-$3.05 adjusted EPS
2026-11-03 19:28:00 UTC#565499newconfirmednews
Pfizer CEO Bourla rules out large acquisitions to focus on integrating Seagen and Metsera assets
2026-11-03 18:16:54 UTC#565156duplicateconfirmednews
Pfizer Q3 revenue hits $16.6B with raised FY26 guidance
2026-11-03 17:55:21 UTC#565036duplicatereportednews
Midday Roundup: Trump reiterates plan to end Israel aid; Pfizer raises 2026 outlook
2026-11-03 17:31:00 UTC#564891newconfirmedanalysis
WSJ Health Care Market Talk: Insights on AstraZeneca, Pfizer, and Bayer
2026-11-03 14:57:03 UTC#563818newconfirmednews
Pfizer Inc. Q3 2026 earnings call begins
2026-11-03 14:53:00 UTC#563921duplicateconfirmednews
Pfizer reports Q3 revenue of $16.58B, beating estimates as company pivots to oncology and weight-loss drugs
2026-11-03 14:35:07 UTC#563618duplicateconfirmednews
Pfizer raises full-year outlook following Q3 earnings beat driven by non-Covid drug demand
2026-11-03 13:43:00 UTC#563286updateconfirmednews
Pfizer reports 25% Q3 sales growth for Eliquis on higher US prices and global demand
2026-11-03 13:26:29 UTC#563476duplicateconfirmednews
Pfizer forecasts higher profits as non-Covid drug demand offsets declining pandemic product sales
2026-11-03 13:26:29 UTC#563231duplicateconfirmednews
Pfizer raises 2026 financial outlook driven by non-Covid drug demand
2026-11-03 13:13:10 UTC#563039duplicateconfirmednews